Skip to main content
. Author manuscript; available in PMC: 2021 Dec 28.
Published in final edited form as: J Clin Epidemiol. 2021 Sep 3;140:101–110. doi: 10.1016/j.jclinepi.2021.09.001

Table 5:

Percentage with viral load monitoring before and after national Treat-All policy adoption by country and sex.

Lesotho Malawi Mozambique South Africa Zambia Zimbabwe

Female patients 861 (100%) 6,493 (100%) 4,921 (100%) 10,743 (100%) 69,687 (100%) 3,865 (100%)
 before Treat-All 416 (48%) 4,096 (63%) 2,412 (49%) 5,768 (54%) 36,618 (53%) 2,244 (58%)
 after Treat-All 445 (52%) 2,397 (37%) 2,509 (51%) 4,975 (46%) 33,069 (47%) 1,621 (42%)
Risk difference at threshold* −0.2 −4.4 3.3 7.1 0.6 1.4
 (95% CI) (−5.8, 5.3) (−10.3, 1.5) (−0.7, 7.3) (1.1, 13.0) (−1.3, 2.5) (−2.9, 5.6)
 p-value 0.944 0.142 0.106 0.020 0.552 0.525
 IK bandwidth (days) 402 131 135 147 143 373
 patients within bandwidth 498 1,810 968 2,778 17,043 2,182

Male patients 448 (100%) 3,422 (100%) 2,374 (100%) 4,873 (100%) 39,849 (100%) 2,110 (100%)
 before Treat-All 210 (47%) 1,975 (58%) 1,009 (42%) 2,548 (52%) 20,333 (51%) 1,105 (52%)
 after Treat-All 238 (53%) 1,447 (42%) 1,365 (58%) 2,325 (48%) 19,516 (49%) 1,005 (48%)
Risk difference at threshold* NA 3.3 0.7 −4.2 1.7 0.1
 (95% CI) NA (−5.5, 12.1) (−2.2, 3.7) (−9.8, 1.4) (−0.8, 4.1) (−6.4, 6.6)
 p-value NA 0.464 0.627 0.144 0.178 0.967
 IK bandwidth (days) NA 117 208 356 181 224
 patients within bandwidth NA 941 803 3,187 12,218 808

Abbreviation: CI, confidence interval.

*

Risk differences at the national Treat-All policy adoption threshold are from regression discontinuity analyses using Imbens-Kalyanaraman (IK) bandwidths derived from all data available within two years before and after the threshold to estimate the difference in local linear predictions. The bandwidth defines the area on each side of the threshold where the relationship between antiretroviral therapy (ART) start and viral load monitoring is assumed to be linear in local linear regression models.